IL-4 induces IL-13-independent allergic airway inflammation

Journal of Allergy and Clinical Immunology

Volumn 118, Issue 2, 2006, Pages 410-419

  Perkins, Charles ^a,b   Wills Karp, Marsha ^a   Finkelman, Fred D ^a,b,c  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Airways hyperresponsiveness; eosinophil; goblet cell; IL 13; IL 4; IL 4 receptor; mouse; mucus

Indexed keywords

CYTOKINE ANTIBODY; CYTOKINE RECEPTOR ANTAGONIST; INTERLEUKIN 13; INTERLEUKIN 4; INTERLEUKIN 4 RECEPTOR; REAGENT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL HYPERPLASIA; COMPARATIVE STUDY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOWN REGULATION; EOSINOPHILIA; FEMALE; GOBLET CELL; IMMUNE RESPONSE; IMMUNOREGULATION; INHALATION TEST; INOCULATION; LUNG LAVAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RESPIRATORY TRACT ALLERGY; RESPIRATORY TRACT INFLAMMATION; SIGNAL TRANSDUCTION;

ANIMALS; ANTIBODIES, MONOCLONAL; BRONCHIAL HYPERREACTIVITY; BRONCHOALVEOLAR LAVAGE FLUID; EOSINOPHILIA; FEMALE; GOBLET CELLS; HYPERPLASIA; IMMUNOGLOBULIN FC FRAGMENTS; INTERLEUKIN-13; INTERLEUKIN-4; LEUKOCYTE COUNT; LUNG; MALE; METHACHOLINE CHLORIDE; MICE; MICE, INBRED BALB C; MICE, NUDE; PNEUMONIA; RECOMBINANT FUSION PROTEINS; RESPIRATORY HYPERSENSITIVITY;

EID: 33746495728     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaci.2006.06.004     Document Type: Article

References (59)

1. Finkelman F.D. Cytokine regulation of type 2 immunity. In: Austen K.F., Frank M.M., Atkinson J.P., and Cantor H. (Eds). Samter's immunological diseases (2001), Lippincott, Williams, and Wilkins, Philadelphia
2. Finkelman F.D., Wynn T.A., Donaldson D.D., and Urban J.F. The role of IL-13 in helminth-induced inflammation and protective immunity against nematode infections. Curr Opin Immunol 11 (1999) 420-426
3. Grunig G., Warnock M., Wakil A.E., Venkayya R., Brombacher F., Rennick D.M., et al. Requirement for IL-13 independently of IL-4 in experimental asthma. Science 282 (1998) 2261-2263
4. Wills-Karp M., Luyimbazi J., Xu X., Schofield B., Neben T.Y., Karp C.L., et al. Interleukin-13: central mediator of allergic asthma. Science 282 (1998) 2258-2261
5. Doucet C., Brouty-Boye D., Pottin-Clemenceau C., Jasmin C., Canonica G.W., and Azzarone B. IL-4 and IL-13 specifically increase adhesion molecule and inflammatory cytokine expression in human lung fibroblasts. Int Immunol 10 (1998) 1421-1433
6. Wills-Karp M. Immunologic basis of antigen-induced airway hyperresponsiveness. Annu Rev Immunol 17 (1999) 255-281
7. Zhu Z., Homer R.J., Wang Z., Chen Q., Geba G.P., Wang J., et al. Pulmonary expression of interleukin-13 causes inflammation, mucus hypersecretion, subepithelial fibrosis, physiologic abnormalities, and eotaxin production. J Clin Invest 103 (1999) 779-788
8. de Vries J.E. The role of IL-13 and its receptor in allergy and inflammatory responses. J Allergy Clin Immunol 102 (1998) 165-169
9. Walter D.M., McIntire J.J., Berry G., McKenzie A.N., Donaldson D.D., DeKruyff R.H., et al. Critical role for IL-13 in the development of allergen-induced airway hyperreactivity. J Immunol 167 (2001) 4668-4675
10. Strait R.T., Morris S.C., Smiley K., Urban Jr. J.F., and Finkelman F.D. IL-4 exacerbates anaphylaxis. J Immunol 170 (2003) 3835-3842
11. Whittaker L., Niu N., Temann U.A., Stoddard A.M., Flavell R.A., Ray A., et al. Interleukin-13 mediates a fundamental pathway for airway epithelial mucus induced by CD4 T cells and interleukin-9. Am J Respir Cell Mol Biol 27 (2002) 593-602
12. Tomkinson A., Duez C., Cieslewicz G., Pratt J.C., Joetham A., Shanafelt M.C., et al. A murine IL-4 receptor antagonist that inhibits IL-4- and IL-13-induced responses prevents antigen-induced airway eosinophilia and airway hyperresponsiveness. J Immunol 166 (2001) 5792-5800
13. Zurawski S.M., Chomarat P., Djossou O., Bidaud C., McKenzie A.N., Miossec P., et al. The primary binding subunit of the human interleukin-4 receptor is also a component of the interleukin-13 receptor. J Biol Chem 270 (1995) 13869-13878
14. Lin J.X., Migone T.S., Tsang M., Friedmann M., Weatherbee J.A., Zhou L., et al. The role of shared receptor motifs and common Stat proteins in the generation of cytokine pleiotropy and redundancy by IL-2, IL-4, IL-7, IL-13, and IL-15. Immunity 2 (1995) 331-339
15. Hilton D.J., Zhang J.G., Metcalf D., Alexander W.S., Nicola N.A., and Willson T.A. Cloning and characterization of a binding subunit of the interleukin 13 receptor that is also a component of the interleukin 4 receptor. Proc Natl Acad Sci U S A 93 (1996) 497-501
16. Wang L.M., Michieli P., Lie W.R., Liu F., Lee C.C., Minty A., et al. The insulin receptor substrate-1-related 4PS substrate but not the interleukin-2R g chain is involved in interleukin-13-mediated signal transduction. Blood 86 (1995) 4218-4227
17. Hershey G.K. IL-13 receptors and signaling pathways: an evolving web. J Allergy Clin Immunol 111 (2003) 677-690
18. Gauchat J.F., Schlagenhauf E., Feng N.P., Moser R., Yamage M., Jeannin P., et al. A novel 4-kb interleukin-13 receptor α mRNA expressed in human B, T, and endothelial cells encoding an alternate type-II interleukin-4/interleukin-13 receptor. Eur J Immunol 27 (1997) 971-978
19. Urban Jr. J.F., Noben-Trauth N., Donaldson D.D., Madden K.B., Morris S.C., Collins M., et al. IL-13, IL-4Rα, and Stat6 are required for the expulsion of the gastrointestinal nematode parasite Nippostrongylus brasiliensis. Immunity 8 (1998) 255-264
20. Kaplan M.H., Schindler U., Smiley S.T., and Grusby M.J. Stat6 is required for mediating responses to IL-4 and for development of Th2 cells. Immunity 4 (1996) 313-319
21. Nelms K., Keegan A.D., Zamorano J., Ryan J.J., and Paul W.E. The IL-4 receptor: signaling mechanisms and biologic functions. Annu Rev Immunol 17 (1999) 701-738
22. Chomarat P., and Banchereau J. Interleukin-4 and interleukin-13: their similarities and discrepancies. Int Rev Immunol 17 (1998) 1-52
23. Obiri N.I., Leland P., Murata T., Debinski W., and Puri R.K. The IL-13 receptor structure differs on various cell types and may share more than one component with IL-4 receptor. J Immunol 158 (1997) 756-764
24. Schnyder B., Lugli S., Feng N., Etter H., Lutz R.A., Ryffel B., et al. Interleukin-4 (IL-4) and IL-13 bind to a shared heterodimeric complex on endothelial cells mediating vascular cell adhesion molecule-1 induction in the absence of the common gamma chain. Blood 87 (1996) 4286-4295
25. He Y.W., and Malek T.R. The IL-2 receptor gamma c chain does not function as a subunit shared by the IL-4 and IL-13 receptors. Implication for the structure of the IL-4 receptor. J Immunol 155 (1995) 9-12
26. c)- and Jak3- dependent signaling in the proliferation and survival of murine mast cells. Blood 96 (2000) 2172-2180
27. Lutz M.B., Schnare M., Menges M., Rossner S., Rollinghoff M., Schuler G., et al. Differential functions of IL-4 receptor types I and II for dendritic cell maturation and IL-12 production and their dependency on GM-CSF. J Immunol 169 (2002) 3574-3580
28. McKenzie G.J., Bancroft A., Grencis R.K., and McKenzie A.N. A distinct role for interleukin-13 in Th2-cell-mediated immune responses. Curr Biol 8 (1998) 339-342
29. Kuperman D.A., Huang X., Koth L.L., Chang G.H., Dolganov G.M., Zhu Z., et al. Direct effects of interleukin-13 on epithelial cells cause airway hyperreactivity and mucus overproduction in asthma. Nat Med 8 (2002) 885-889
30. Cohn L., Whittaker L., Niu N., and Homer R.J. Cytokine regulation of mucus production in a model of allergic asthma. Novartis Found Symp 248 (2002) 201-220 77-82
31. Larche M., Robinson D.S., and Kay A.B. The role of T lymphocytes in the pathogenesis of asthma. J Allergy Clin Immunol 111 (2003) 450-463
32. Terabe M., Matsui S., Noben-Trauth N., Chen H., Watson C., Donaldson D.D., et al. NKT cell-mediated repression of tumor immunosurveillance by IL-13 and the IL-4R-STAT6 pathway. Nat Immunol 1 (2000) 515-520
33. Marshall M.A., Jankovic D., Maher V.E., Sher A., and Berzofsky J.A. Mice infected with Schistosoma mansoni develop a novel non-T-lymphocyte suppressor population which inhibits virus-specific CTL induction via a soluble factor. Microbes Infect 3 (2001) 1051-1061
34. Finkelman F.D., Yang M., Perkins C., Schleifer K., Sproles A., Santeliz J., et al. Suppressive effect of IL-4 on IL-13-induced genes in mouse lung. J Immunol 174 (2005) 4630-4638
35. 1 production and fibrosis. Nat Med 12 (2006) 99-106
36. Chiaramonte M.G., Donaldson D.D., Cheever A.W., and Wynn T.A. An IL-13 inhibitor blocks the development of hepatic fibrosis during a T-helper type 2-dominated inflammatory response. J Clin Invest 104 (1999) 777-785
37. 2 during a T helper cell type 2-dominant immune response. J Exp Med 197 (2003) 687-701
38. 2. J Exp Med 197 (2003) 703-709
39. McKenzie G.J., Emson C.L., Bell S.E., Anderson S., Fallon P., Zurawski G., et al. Impaired development of Th2 cells in IL-13-deficient mice. Immunity 9 (1998) 423-432
40. Abrams J.S., Roncarolo M.G., Yssel H., Andersson U., Gleich G.J., and Silver J.E. Strategies of anti-cytokine monoclonal antibody development: immunoassay of IL-10 and IL-5 in clinical samples. Immunol Rev 127 (1992) 5-24
41. Beckmann M.P., Schooley K.A., Gallis B., Vanden Bos T., Friend D., Alpert A.R., et al. Monoclonal antibodies block murine IL-4 receptor function. J Immunol 144 (1990) 4212-4217
42. Finkelman F.D., Madden K.B., Morris S.C., Holmes J.M., Boiani N., Katona I.M., et al. Anti-cytokine antibodies as carrier proteins. Prolongation of in vivo effects of exogenous cytokines by injection of cytokine-anti-cytokine antibody complexes. J Immunol 151 (1993) 1235-1244
43. Hamelmann E., Schwarze J., Takeda K., Oshiba A., Larsen G.L., Irvin C.G., et al. Noninvasive measurement of airway responsiveness in allergic mice using barometric plethysmography. Am J Respir Crit Care Med 156 (1997) 766-775
44. McKenzie G.J., Fallon P.G., Emson C.L., Grencis R.K., and McKenzie A.N. Simultaneous disruption of interleukin (IL)-4 and IL-13 defines individual roles in T helper cell type 2-mediated responses. J Exp Med 189 (1999) 1565-1572
45. Urban Jr. J.F., Schopf L., Morris S.C., Orekhova T., Madden K.B., Betts C.J., et al. Stat6 signaling promotes protective immunity against Trichinella spiralis through a mast cell- and T cell-dependent mechanism. J Immunol 164 (2000) 2046-2052
46. Finkelman F.D., Morris S.C., Orekhova T., Mori M., Donaldson D., Reiner S.L., et al. Stat6 regulation of in vivo IL-4 responses. J Immunol 164 (2000) 2303-2310
47. Dombrowicz D., Flamand V., Miyajima I., Ravetch J.V., Galli S.J., and Kinet J.P. Absence of Fcε{lunate}RIα; chain results in upregulation of Fc gammaRIII-dependent mast cell degranulation and anaphylaxis. Evidence of competition between Fcε{lunate}RI and FcγRIII for limiting amounts of FcR β and γ chains. J Clin Invest 99 (1997) 915-925
48. Wills-Karp M., and Chiaramonte M. Interleukin-13 in asthma. Curr Opin Pulm Med 9 (2003) 21-27
49. Shim J.J., Dabbagh K., Ueki I.F., Dao-Pick T., Burgel P.R., Takeyama K., et al. IL-13 induces mucin production by stimulating epidermal growth factor receptors and by activating neutrophils. Am J Physiol Lung Cell Mol Physiol 280 (2001) L134-L140
50. Cohn L., Homer R.J., Marinov A., Rankin J., and Bottomly K. Induction of airway mucus production by T helper 2 (Th2) cells: a critical role for interleukin 4 in cell recruitment but not mucus production. J Exp Med 186 (1997) 1737-1747
51. Rankin J.A., Picarella D.E., Geba G.P., Temann U.A., Prasad B., DiCosmo B., et al. Phenotypic and physiologic characterization of transgenic mice expressing interleukin 4 in the lung: lymphocytic and eosinophilic inflammation without airway hyperreactivity. Proc Natl Acad Sci U S A 93 (1996) 7821-7825
52. Venkayya R., Lam M., Willkom M., Grunig G., Corry D.B., and Erle D.J. The Th2 lymphocyte products IL-4 and IL-13 rapidly induce airway hyperresponsiveness through direct effects on resident airway cells. Am J Respir Cell Mol Biol 26 (2002) 202-208
53. Kuperman D., Schofield B., Wills-Karp M., and Grusby M.J. Signal transducer and activator of transcription factor 6 (Stat6)- deficient mice are protected from antigen-induced airway hyperresponsiveness and mucus production. J Exp Med 187 (1998) 939-948
54. Finkelman F. Cytokine regulation of type 2 immunity. In: Austen K.F., Frank M.M., Atkinson J.P., and Cantor H. (Eds). Samter's immunologic diseases. 6th ed. (2001), Lippincott Williams & Wilkins, Philadelphia 111-126
55. Whittaker L., Niu N., Temann U.A., Stoddard A., Flavell R.A., Ray A., et al. Interleukin-13 mediates a fundamental pathway for airway epithelial mucus induced by CD4 T cells and interleukin-9. Am J Respir Cell Mol Biol 27 (2002) 593-602
56. Hurst S.D., Muchamuel T., Gorman D.M., Gilbert J.M., Clifford T., Kwan S., et al. New IL-17 family members promote Th1 or Th2 responses in the lung: in vivo function of the novel cytokine IL-25. J Immunol 169 (2002) 443-453
57. Cohn L., Homer R.J., MacLeod H., Mohrs M., Brombacher F., and Bottomly K. Th2-induced airway mucus production is dependent on IL-4Rα, but not on eosinophils. J Immunol 162 (1999) 6178-6183
58. Ruetten H., and Thiemermann C. Interleukin-13 is a more potent inhibitor of the expression of inducible nitric oxide synthase in smooth muscle cells than in macrophages: a comparison with interleukin-4 and interleukin-10. Shock 8 (1997) 409-414
59. Chilton P.M., and Fernandez-Botran R. Production of soluble IL-4 receptors by murine spleen cells is regulated by T cell activation and IL-4. J Immunol 151 (1993) 5907-5917